… Inhaled corticosteroid (ICS) therapy carries less risk of complicating drug- or disease-… Serious
side effects are uncommon, but the risk increases with the daily dose. The degree of risk is …

… the enhanced risk of pneumonia. Bahçeciler’s study (11) suggested that inhaled corticosteroid
… Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J …

Inhaled corticosteroids (ICS) could increase both the risk of coronavirus disease 2019 (COVID-19)
and experiencing poor outcomes. To compare the clinical outcomes between ICS …

… inhaled corticosteroids has been shown to decrease the risk of death, with the degree of risk
reduction directly correlated to the amount of inhaled … an ideal inhaled corticosteroid for use …

… to explore this risk have had conflicting results. We sought to explore the risk of ICS and …
and those of recent reviews of inhaled corticosteroids and fractures. We considered including …

… Compared with placebo, participants assigned to inhaled corticosteroids had a lower risk
of mortality (HR 0.75; 95% CI 0.57 to 0.99; fig 1). Stratification by individual trials and …

… It remains uncertain whether there is a protective effect of inhaled corticosteroids (ICs) … use
of ICs in COPD patients was associated with a decreased risk of lung cancer [HR: 0.73, 95% …

… of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia with long-term
inhaled corticosteroid use among patients with chronic obstructive pulmonary disease (COPD). …

Introduction: Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease. To estimate the association between ICS …

… The use of inhaled corticosteroids has been associated with an increased risk of pneumonia
in … has not been previously evaluated in patients with asthma using inhaled corticosteroids. …